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OBJECTIVE — To examine the association between baseline elevated depressive symptoms
and incident type 2 diabetes in a national sample of people aged 50 years.
RESEARCH DESIGN AND METHODS — The sample consisted of 6,111 individuals
free from self-reported doctor-diagnosed diabetes at baseline in 2002–2003. The eight-item
Center for Epidemiological Studies–Depression (CES-D) scale was the measurement of depres-
sive symptoms. Cox proportional hazards regression models were used to assess whether base-
lineelevated(4)depressivesymptomswereassociatedwithahigherriskoftype2diabetesover
45.8 months of follow-up.
RESULTS — The hazard ratio (HR) for diabetes was 1.62 (95% CI 1.15–2.29) in a model
adjusted for age, sex, marital status, education, total net household wealth, cardiovascular and
psychiatric and other noncardiovascular comorbidities, BMI, and health behaviors for partici-
pants with elevated CES-D symptoms compared with those without. Complementary analysis
performed for a subsample (n  5,090) showed that additional adjustment of this model for use
of antidepressants did not explain the association (HR 1.58, 95% CI 1.09–2.29).
CONCLUSIONS — Elevated depressive symptoms were associated with a higher risk of
developing type 2 diabetes after accounting for sociodemographic, lifestyle, and clinical factors
in a national sample of people aged 50 years.
Diabetes Care 33:792–797, 2010
D
epression is a known comorbid
condition of diabetes. Individuals
with diabetes have increased odds
of being depressed and consistently
higher prevalence rates of depression
than their counterparts without diabetes
(1). An accumulating body of research
shows that type 2 diabetes is a risk factor
for recurrent depression (2), but longitu-
dinal studies also suggest that depression
and elevated depressive symptoms are re-
lated to subsequent incidence of diabetes
(3–10). Two recent meta-analyses of lon-
gitudinal studies suggest that depression
is associated with a 40–60% increased
risk of developing type 2 diabetes
(11,12). The etiology and pathogenic
mechanism of this association is poorly
understood. It has been suggested that
unhealthy behaviors (i.e., physical inac-
tivity and smoking), obesity, and use of
psychotropic medication may be parts of
the causal pathway linking depression to
type 2 diabetes (3,11,13).
The majority of previous longitudinal
studies on the association between de-
pressive symptoms and incident diabetes
have not accounted adequately for socio-
economicstatus(SES),andthereforetheir
results might be biased because of resid-
ual confounding. They have also gener-
ally failed to account for baseline
comorbidities such as cardiovascular,
noncardiovascular, and psychiatric dis-
eases, which might explain the associa-
tion between depression and diabetes.
Moreover,moreresearchisneededonthe
use of antidepressants and other psycho-
tropic medication as a depression-related
risk factor for diabetes in older samples,
since evidence on this issue is conﬂicting
(6,8,9,14).
We used data from the English Lon-
gitudinal Study of Aging (ELSA), a na-
tional prospective cohort study of
community-dwelling middle-aged and
older men and women, to examine
whether baseline elevated depressive
symptoms measured by the Center for
Epidemiological Studies–Depression
(CES-D) scale were associated with a
higher risk of developing type 2 diabetes.
We adjusted for a wide range of potential
confounders including education and
wealth as markers of SES and baseline co-
morbidities including psychiatric dis-
eases. We then explored whether health
behaviors, BMI, and use of antidepres-
sants or other psychotropic medication
mediated the association between ele-
vated baseline depressive symptoms and
incident type 2 diabetes.
RESEARCH DESIGN AND
METHODS— The baseline ELSA in-
terview (wave 1) in 2002–2003 included
11,523 community-dwelling individuals
aged50years.Theﬁrstfollow-upinter-
view was in 2004–2005 (wave 2) and the
second was in 2006–2007 (wave 3). A
physical examination took place in paral-
lel with the ﬁrst follow-up interview in
2004–2005 (nurse visit, wave 2). The
ELSA sample was designed to be repre-
sentative of the population of communi-
ty-dwelling adults aged 50 years in
England. It was drawn from households
thathadparticipatedintheHealthSurvey
for England (HSE) in 1998, 1999, and
2001, which is an annual cross-sectional
health survey that uses nationally repre-
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that contained at least one person aged
50 years who had consented to be re-
contacted in the future were eligible for
inclusionintheELSAsample(n11,373
households). The ELSA wave 1 sample
consisted of 7,935 out of the 11,371 eli-
gible HSE households (response rate
70%). HSE data predating ELSA baseline
were therefore available for the ELSA par-
ticipants (these data are known as ELSA
wave 0).
Participantswithmissinginformation
on self-reported diabetes status or date of
diagnosis of diabetes (n  18), or missing
values in any of the employed covariates
(n  2,439) along with participants who
had no longitudinal data available (n 
2,078)orwereprevalentcasesofdiabetes
atbaseline(n877),wereexcludedfrom
analysis. The ﬁnal sample for the main
analysis consisted of 6,111 individuals
(55.7% women). Individuals who
droppedoutofthestudyafterhavingpar-
ticipated in its ﬁrst wave were more likely
to be older, male, of lower SES, more de-
pressed, and have more chronic diseases
than individuals who have not dropped
out.
Assessment of diabetes
The outcome measure was incident self-
reported doctor-diagnosed type 2 diabe-
tes, i.e., new cases of self-reported type 2
diabetesthatwerediagnosedafterwave1.
Because diabetes medication data
were not available in wave 1, we investi-
gated the degree of possible misclassiﬁca-
tion of diagnosed diabetes in our sample
by using data on the use of diabetes med-
icationfromwave0.Thiswascollectedby
nurses who inspected and registered all
medication taken by the participants.
Medication information was available for
the majority of the analytic sample (n 
5,092 of the 6,113 who were initially se-
lected for inclusion in the analytic sam-
ple). Among the 5,092 participants with
medication data, there were only two in-
dividuals who had been misclassiﬁed as
free of diabetes at baseline, while taking
diabetes medication at wave 0, and who
werethusexcludedfromanalysisasprev-
alent cases of diabetes. This result sug-
geststhatthereisminimalunderreporting
of diagnosed diabetes. The date of diag-
nosis of diabetes (month/year) used to
calculate the follow-up time was also
self-reported.
Measurement of depressive
symptoms
The eight-item CES-D scale was the mea-
surement of depressive symptoms at
baseline (15). CES-D measures self-
reported depressive symptomatology
and, although not a clinical diagnostic
tool, it is widely used to identify people
“at risk” of depression (16). The eight-
item version we used had good internal
consistency (Cronbach’s  around 0.8 in
repeated measurements) and other psy-
chometric values comparable to the full
20-itemCES-D(15).WederivedaCES-D
summary score by summing responses to
all eight dichotomous questions. We di-
chotomized the summary score using a
cut point of four or higher (4), which is
equivalent to the conventional cut point
of 16 or higher on the full 20-item CES-D
(15).
Measurement of covariates
Baseline sociodemographic, clinical, and
lifestyle variables were used as covariates,
since they are established risk factors for
diabetes. Age was recorded as a continu-
ous variable in years, with all participants
aged over 90 years being assigned the
value of 91. SES was assessed by educa-
tional attainment (university degree or
equivalent, higher education but not uni-
versity degree, A-level, O-level, second-
ary education, some foreign educational
qualiﬁcations, or no educational qualiﬁ-
cations) and by total net nonpension
household wealth (household is deﬁned
asacouplewithanydependentchild)cat-
egorized using quintiles. Smoking (cur-
rent smoker, exsmoker, never a smoker),
frequency of alcohol consumption in the
last 12 months (more than once a day,
daily or almost daily, once or twice a
week, once or twice a month, on special
occasions only, not at all), and physical
activityonaweeklybasis(vigorous,mod-
erate, mild, not at all) were also assessed.
Information on marital status, existence
of any longstanding illness or disability,
and self-reported doctor-diagnosed car-
diovascular (hypertension, angina, heart
attack, congestive heart failure, heart
murmur, abnormal heart rhythm and
stroke) and noncardiovascular morbidi-
ties including psychiatric diseases and
cognitive impairments (chronic lung dis-
ease, asthma, arthritis, osteoporosis, can-
cer/malignant tumor excluding minor
skin cancers, Parkinson’s disease, emo-
tional/nervous/psychiatricproblems,Alz-
heimer’s disease, and dementia or other
serious memory impairment) was also
collected during the interviews. Because
noanthropometricdataweremeasuredat
baseline (wave 1), we used the average of
BMImeasurementsfromwave0andwave
2asanestimateofBMIatwave1.BMIwas
calculated from objective measurements
ofheightandweighttakenbynursesdur-
ing a clinical examination. Details of the
measurement protocol can be found at
http://www.ifs.org.uk/elsa/docs_w2/
project_instructions_nurse.pdf. Informa-
tion about use of antidepressants and
other psychotropic medications (i.e., an-
tipsychotics and anxiolytics) was col-
lected by nurses during wave 0.
Statistical analysis
Baselinecharacteristicswereexaminedby
CES-D symptom categories. Diabetes in-
cidence rates for each CES-D symptom
category were calculated. The association
between baseline CES-D symptom cate-
gories and incident diabetes was assessed
by Cox proportional hazards regression
models.Coxproportionalhazardsregres-
sion models were also used to conﬁrm
that BMI, health behaviors, and use of an-
tidepressants were associated with diabe-
tes and may therefore be mediators of the
association between depressive symp-
toms and incident diabetes. Follow-up
time was calculated as the time elapsed
from the date of baseline interview to the
ﬁrst of either the date of diagnosis of dia-
betes or the date of the last ELSA inter-
viewinwhichtheindividualparticipated.
Graphical plots (log-negative log survival
plots) and statistical tests (Schoenfeld re-
sidualstest)wereusedtoconﬁrmthepro-
portional hazards assumption. We
assessed whether there were signiﬁcant
interactions between CES-D symptom
categories and age and sex to investigate
whether the association between depres-
sive symptoms and incident diabetes var-
ied by age or between men and women.
As there were no signiﬁcant interactions,
we ﬁtted a model adjusted for age and
then additionally for sex, marital status,
comorbidities,andSES.Wethenadjusted
this basic model for BMI and health be-
haviors, ﬁrst individually and then
jointly, to estimate the effect of these fac-
torsontheexaminedassociation.Wealso
assessed the percentage reduction in the
depressive symptoms–related hazard ra-
tio(HR)asBMIandhealthbehaviorswere
added to the basic model. In addition, we
assessed whether use of antidepressants
or other psychotropic medication medi-
ated the association of interest in a sub-
sample of 5,090 individuals with
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a model adjusted for all confounders and
mediators, and then we additionally ad-
justed this model for use of antidepres-
sants or antidepressants and other
psychotropic medication (i.e., antipsy-
chotics and anxiolytics).
On the basis that the association be-
tween elevated depressive symptoms and
diabetes might be causal, we calculated
the fully adjusted population-attributable
fraction (that is, the percentage of cases of
diabetesthatcouldhavebeenpreventedif
all respondents were free of elevated de-
pressive symptoms). For purposes of
comparison, we also calculated the fully
adjusted population-attributable frac-
tions for covariates that were important
known risk factors for diabetes, such as
obesity and physical activity.
We assessed the possible impact of
reverse causality (undiagnosed diabetes
causing baseline depression) by repeating
our multivariable analyses after the re-
movalofallincidentcasesofdiabetesthat
were diagnosed within the ﬁrst 12
months after baseline (n  6,086). Sensi-
tivity analyses were also performed to as-
sess the impact of missing data by
repeatinganalyses(exceptmodelsinclud-
ing BMI and use of antidepressants and
other psychotropic medication) in a
larger sample (n  8,228), including all
individuals who were excluded from the
mainanalysisbecauseofmissingBMIval-
ues. All analyses were performed using
STATA 9.2.
RESULTS— Alldifferencesinbaseline
characteristics between the CES-D symp-
tom categories were signiﬁcant except for
age differences. Participants who re-
portedelevatedCES-Dsymptomsatbase-
line were more likely to be female, less
educated, less wealthy, current smokers,
and suffer from cardiovascular and other
noncardiovascular chronic diseases than
those who reported less than four or no
CES-D symptoms. They were also less
likelytobemarried,physicallyactive,and
consume alcohol frequently. Difference
between the two categories in BMI was
marginally signiﬁcant (Table 1). BMI,
health behaviors, and use of antidepres-
sants were also related to incident diabe-
tes (data not shown).
A total of 209 incident cases of type 2
diabetes were reported over an average of
45.8 months of follow-up. Participants
with elevated CES-D symptoms had
higher incidence of diabetes (16.7 per
1,000 person-years) than individuals
Table 1—Baseline characteristics of 6,111 men and women without prevalent type 2 diabetes
by baseline depressive symptoms: English Longitudinal Study of Aging, 2002–2003
CES-D 4 CES-D 4 P
n 5,288 823
Age (years) 63.6  9.3 64.0  9.8 0.24
Sex 0.001
Male 2,453 (46.4) 256 (31.1)
Female 2,835 (53.6) 567 (68.9)
Marital status 0.001
Nonmarried 1,506 (28.5) 388 (47.1)
Married 3,782 (71.5) 435 (52.9)
Education 0.001
Degree or equivalent 706 (13.3) 59 (7.2)
Higher education or equivalent 687 (13.0) 72 (8.7)
General certiﬁcate of education:
advanced level or equivalent 376 (7.1) 45 (5.5)
General certiﬁcate of education:
ordinary level or equivalent 977 (18.5) 126 (15.3)
Certiﬁcate of secondary education 245 (4.6) 36 (4.4)
Foreign or other type of
qualiﬁcations 481 (9.1) 64 (7.8)
No qualiﬁcation 1,816 (34.4) 421 (51.1)
Total net non-pension household
wealth* median (interquartile
range) (£) 160,010 (217,490) 81,962 (175,950) 0.001
Any longstanding illness or disability 0.001
No 2,735 (51.7) 233 (28.3)
Yes 2,553 (48.3) 590 (71.7)
Cardiovascular comorbidity† 0.001
No cardiovascular disease 2,984 (56.4) 409 (49.7)
At least one cardiovascular disease 2,304 (43.6) 414 (50.3)
Other noncardiovascular comorbidity† 0.001
No noncardiovascular disease 2,862 (54.1) 245 (29.8)
At least one noncardiovascular
disease 2,426 (45.9) 578 (70.2)
Smoking status 0.001
Never a smoker 2,024 (38.3) 245 (29.8)
Exsmoker 2,447 (46.3) 353 (42.9)
Current smoker 817 (15.4) 225 (27.3)
Physical activity at least once a week 0.001
Not at all 274 (5.2) 106 (12.9)
Mild 562 (10.6) 178 (21.6)
Moderate 2,658 (50.3) 380 (46.2)
Vigorous 1,794 (33.9) 159 (19.3)
Frequency of alcohol consumption 0.001
Twice a day or more often 217 (4.1) 27 (3.3)
Daily or almost daily 1,365 (25.8) 182 (22.1)
Once or twice a week 1,800 (34.0) 205 (24.9)
Once or twice a month 593 (11.2) 86 (10.6)
Only on special occasions 898 (17.0) 200 (24.3)
Not at all 415 (7.9) 123 (14.9)
BMI (kg/m
2) 27.5  4.4 27.8  5.0 0.045
DataaremeansSDorn(%)unlessotherwiseindicated.*Thisistotalhouseholdwealth(excludingpension
savings)minushouseholddebt.†Cardiovascularcomorbiditiesincludedhypertension,angina,heartattack,
congestive heart failure, heart murmur, abnormal heart rhythm, and stroke; noncardiovascular comorbidi-
ties included chronic lung disease, asthma, arthritis, osteoporosis, cancer/malignant tumor excluding minor
skincancers,Parkinson’sdisease,emotional/nervous/psychiatricproblems,Alzheimer’sdisease,anddemen-
tia or other serious memory impairment.
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(Table 2).
The HR for diabetes was 2.14 (95%
CI 1.56–2.94) in the age-adjusted model
for participants with elevated CES-D
symptoms compared with individuals
without (Table 2). Adjusting for other so-
ciodemographic characteristics, comor-
bidities, and SES reduced the HR, but
thereremainedanincreasedriskofdiabe-
tes in individuals with depressive symp-
toms. Additional adjustment for BMI did
not affect the association, whereas addi-
tional adjustment for health behaviors re-
duceditsstrength,butdidnotcompletely
explain it (22% reduction in the HR be-
tween the latter model and the reference
model that was adjusted for sociodemo-
graphic characteristics, comorbidities,
and SES) (Table 2). The association be-
tween depressive symptoms and incident
diabetes remained signiﬁcant, even after
adjustingforallcovariates(HR1.62,95%
CI 1.15–2.29) (16% reduction in the HR
between this model and the reference
model) (Table 2). The percentage of cases
of diabetes that could have been pre-
vented if none of the respondents were
exposedtoelevateddepressivesymptoms
was 9% (95% CI 2–17%). The respec-
tive estimates for obesity (if all respon-
dents had BMI 30 kg/m
2) and physical
activity (if all respondents performed vig-
orous/moderate-intensity physical activ-
ity more than once a week) were 30%
(95% CI 20–39%) and 16% (4–27%),
respectively.
The association between elevated de-
pressive symptoms and incident diabetes
remained signiﬁcant, even when incident
cases of diabetes that were diagnosed
within the ﬁrst 12 months after baseline
were excluded from analysis (HR 1.49,
95% CI 1.02–2.16). Moreover, elevated
depressive symptoms were signiﬁcantly
relatedtoincidentdiabetesinamodelad-
justed for all covariates (1.63, 1.13–2.36)
forthesubsampleof5,090individualsfor
whom information on use of medication
was available. Adjustment of this model
for use of antidepressants (1.58, 1.09–
2.29)orantidepressantsandotherpsych-
otropic medication (i.e., antipsychotics
and anxiolytics) (1.60, 1.11–2.32) did
not explain the examined association.
The sensitivity analysis performed in
a larger sample that included in addition
cases with missing BMI values showed
that depression remained associated with
diabetesinamodeladjustedforallcovari-
atesexceptforBMIanduseofantidepres-
sants or other psychotropic medication
irrespective of missing data (HR 1.38,
95% CI 1.03–1.85), although the esti-
mated association was weaker in this
larger sample.
CONCLUSIONS — In a national sam-
ple of men and women aged 50 years,
we found that elevated depressive
(CES-D) symptoms at baseline were asso-
ciated with a higher risk of developing
type 2 diabetes. This association did not
vary according to age and sex and was
largely independent of known correlates
ofdiabetesanddepressionandcardiovas-
cular, psychiatric, and other comorbidi-
ties. Hypothesized mechanisms through
which elevated depressive symptoms
might affect incident diabetes involving
health behaviors, BMI, and use of anti-
depressants explained little or nothing
of the association. From a public health
perspective, the burden of diabetes that
could be attributed to elevated depres-
sive symptoms was comparable, al-
though less, to the burden of diabetes
that can be attributed to the lack of
physical activity.
In accordance with most previous
studies and two recent meta-analyses
(11,12), we found that elevated CES-D
symptoms were associated with a higher
riskofdevelopingtype2diabetes.Also,in
agreement with previous studies (7), we
foundthatbaselinesomaticcomorbidities
did not confound this association. In ad-
dition, we found that baseline psychiatric
comorbidities and cognitive impairments
similarly did not confound this associa-
tion. To our knowledge, this article is the
ﬁrst to adjust simultaneously for such a
wide array of baseline somatic and psy-
chiatric comorbidities.
Most previous studies have adjusted
their models for a single SES indicator
(typically, this was education) (4,6–9).
We accounted for SES in a more satisfac-
tory way by adjusting not only for educa-
tion but also for total net household
wealth, which has been found to be re-
latedtodiabetesmorestronglythanother
indicators of SES in our sample (17). We
still found, in accordance with all previ-
ous reports, that SES did not fully explain
the association between elevated depres-
sive symptoms and incident diabetes. We
did demonstrate, however, that SES had
the strongest individual confounding ef-
fect on the association between baseline
depressive symptoms and incident
diabetes.
Table 2—Incidence and HRs (95% CI) of type 2 diabetes by baseline depressive symptoms in
6,111 men and women: English Longitudinal Study of Aging, 2002–2007
CES-D 4 CES-D 4
n 5,288 823
Incidence
Incident cases (n) 158 51
Follow-up (person-years) 20,262 3,051
Incidence rate of type 2 diabetes (per 1,000
person-years) 7.8 16.7
Cox regression models*
Model 1: adjusted for age (linear term) 1.0 (reference category) 2.14 (1.56–2.94)
Model 2: model 1  adjusted for age
(quadratic term), sex, marital status, self-
reported longstanding illness or disability,
and cardiovascular and noncardiovascular
comorbidities† 1.0 (reference category) 2.00 (1.44–2.79)
Model 3: model 2  adjusted for educational
attainment and total household wealth‡ 1.0 (reference category) 1.74 (1.24–2.45)
Model 4: model 3  adjusted for BMI 1.0 (reference category) 1.76 (1.25–2.46)
Model 5: model 3  adjusted for health
behaviors 1.0 (reference category) 1.58 (1.12–2.24)
Model 6: model 3  adjusted for BMI and
health behaviors 1.0 (reference category) 1.62 (1.15–2.29)
*Results are presented in the form of HR (95% CI). †Cardiovascular comorbidities included hypertension,
angina, heart attack, congestive heart failure, heart murmur, abnormal heart rhythm, and stroke. Noncar-
diovascular comorbidities included chronic lung disease, asthma, arthritis, osteoporosis, cancer/malignant
tumor excluding minor skin cancers, Parkinson’s disease, emotional/nervous/psychiatric problems, Alzhei-
mer’sdisease,anddementiaorotherseriousmemoryimpairment.‡Thisistotalhouseholdwealth(excluding
pension savings) minus household debt.
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healthy behaviors would be potential
mechanisms linking depression to diabe-
tes. Depression can lead to obesity, which
is a major risk factor for diabetes through
stimulatingincreasedactivityofthehypo-
thalamic-pituitary-adrenocortical axis
and sympathetic nervous system (11).
Moreover, depression is related to un-
healthy behaviors such as physical inac-
tivity and smoking (18), which are also
risk factors for diabetes (19,20). How-
ever, we found that neither BMI, despite
being a powerful correlate of incident di-
abetes, nor health behaviors substantially
mediated the association between CES-D
and diabetes. These ﬁndings are in agree-
ment with most but not all (6) previous
studies, which have shown that neither
BMI nor health behaviors fully explained
the observed association (3–5,7–10). We
alsofoundthatuseofantidepressantsand
other psychotropic medication could not
explain the observed association. This is
consistent with the ﬁndings of most
(6,8,9) but not all (14) previous studies
and with our ﬁnding that obesity did not
mediate the association between depres-
sionanddiabetes,sinceuseofantidepres-
sants was expected to affect diabetes
largely through change in weight (21).
Our ﬁndings in relation to use of antide-
pressants should be treated with some
caution, since data on use of antidepres-
sants and other psychotropic medication
predate the ELSA baseline data.
Future research on the mechanism of
the association between elevated depres-
sive symptoms and incident diabetes
should concentrate on factors other than
obesity, unhealthy behaviors, and use of
antidepressants. It is possible that there
are common causes underlying the rela-
tionship, such as factors from early life
that are risk factors for both depression
and diabetes. Low birth weight has been
found to be related to diabetes (22) and
possibly with depressive symptoms (23).
Further, low birth weight has been found
to modify the association of diabetes or
cardiovascular disease with depression in
a sample of older adults (24). Alterna-
tively, there may be biological pathways
where depression leads to biological
changes, which then result in diabetes
(11,13,21).Biologicalpathwaysrelatedto
glucosehomeostasissuchashypothalam-
ic-pituitary-adrenocortical axis dysregu-
lation and sympathetic nervous system
stimulation warrant further exploration
(21). Inﬂammation is another candidate
pathway,butwasfoundnottoexplainthe
association between depression and dia-
betes in recent studies (8,10).
The use of a large national sample of
community-dwelling men and women
aged 50 years is a major advantage of
ourstudy.ThedetailedassessmentofSES
and background psychiatric, cognitive,
and physical health problems means that
appropriate adjustment was made for a
wide range of potential confounding vari-
ables.Accountingforbothwealthanded-
ucation diminished the chances of
residual confounding because of inade-
quate adjustment for SES and therefore
strengthened previous evidence that SES
did not fully explain the association be-
tween depressive symptoms and incident
diabetes. CES-D measures depressive
symptoms experienced in the past week
and, therefore, does not account for his-
tory of depression. By accounting for
baseline psychiatric comorbidities, we
showed that elevated baseline depressive
symptoms were related to a higher risk of
diabetes irrespective of background de-
pressive disorder or other psychiatric
disease.
A limitation of our study is the use of
self-reported diabetes as the outcome
measure. However, comparing baseline
self-reported diabetes with objective in-
formation about the use of diabetes med-
ication from wave 0 indicated minimal
misclassiﬁcation of cases of diagnosed di-
abetes. The possibility of undiagnosed di-
abetes inﬂuencing our ﬁndings remains.
A recent cross-sectional study using data
from wave 2 indicated that 18.5% (n 
36) of all cases of diabetes in the ELSA
sample were undiagnosed (25). Reverse
causality is thus a potential issue, since
there is the possibility that some depres-
sive symptomatology at baseline may be a
result of undetected prevalent cases of di-
abetes. However, elevated CES-D symp-
toms remained related to risk of
developingdiabetes,evenafterhavingex-
cluded from analysis all incident cases of
diabetes that were diagnosed within the
ﬁrst 12 months after the baseline. Fur-
ther, there is evidence showing that un-
treated diabetes is not associated with the
incidence of depressive symptoms (10).
Missing data and attrition are unavoid-
able in large cohorts based on a national
generalpopulationsamplesuchasELSA.In
supplementary analyses, we showed that
our ﬁndings remained similar in a larger
samplethatincludedindividualswithmiss-
ing BMI information. We would expect at-
trition to have made our results more
conservative, since individuals who
droppedoutfromELSAwerelesseducated,
and there is evidence (3,9) that the depres-
sion-relatedriskofdevelopingtype2diabe-
tesishigheramongindividualswhoareless
educated irrespective of age, sex, race,
healthbehaviors,BMI,andfamilyhistoryof
diabetes.
Our research suggests that elevated
depressive symptoms were associated
with a higher risk of developing type 2
diabetes in middle-aged and older adults.
SES and baseline comorbidities including
psychiatric diseases did not fully explain
this association. There was little evidence
that obesity, unhealthy behaviors, or use
of antidepressants substantially mediated
this association. Future research should
explore the etiology and mechanism of
this association. Action to prevent and
treat depression might contribute to the
ﬁght against diabetes.
Acknowledgments— The data were made
availablethroughtheU.K.DataArchive.ELSA
was developed by a team of researchers based
at University College London, the Institute of
Fiscal Studies, and the National Centre for So-
cial Research. Funding was provided by the
National Institute on Aging in the U.S. (grants
2RO1AG7644-01A1 and 2RO1AG017644)
and a consortium of U.K. government depart-
ments coordinated by the Ofﬁce for National
Statistics.ThedevelopersandfundersofELSA
and the Archive do not bear any responsibility
for the analyses or interpretations presented
here.
No potential conﬂicts of interest relevant to
this article were reported.
Earlier versions of this article were pre-
sented at the Diabetes UK Annual Professional
Conference 2009, Glasgow, Scotland, 11–13
March 2009, and the 62nd Annual Scientiﬁc
Meeting of the Gerontological Society of
America, Atlanta, Georgia, 18–22 November
2009.
References
1. Anderson RJ, Freedland KE, Clouse RE,
Lustman PJ. The prevalence of comorbid
depression in adults with diabetes: a
meta-analysis. Diabetes Care 2001;24:
1069–1078
2. Talbot F, Nouwen A. A review of the re-
lationship between depression and diabe-
tesinadults:istherealink?DiabetesCare
2000;23:1556–1562
3. Carnethon MR, Kinder LS, Fair JM, Staf-
ford RS, Fortmann SP. Symptoms of de-
pression as a risk factor for incident
diabetes: ﬁndings from the National
Health and Nutrition Examination Epide-
miologic Follow-up Study, 1971–1992.
Am J Epidemiol 2003;158:416–423
4. Golden SH, Williams JE, Ford DE, Yeh
Depressive symptoms and incident diabetes
796 DIABETES CARE, VOLUME 33, NUMBER 4, APRIL 2010 care.diabetesjournals.orgHC, Sanford CP, Nieto FJ, Brancati FL,
Atherosclerosis Risk in Communities
Study. Depressive symptoms and the risk
of type 2 diabetes: the Atherosclerosis
Risk in Communities study. Diabetes
Care 2004;27:429–435
5. Arroyo C, Hu FB, Ryan LM, Kawachi I,
Colditz GA, Speizer FE, Manson J. De-
pressive symptoms and risk of type 2 di-
abetes in women. Diabetes Care 2004;27:
129–133
6. Everson-Rose SA, Meyer PM, Powell LH,
Pandey D, Torre ´ns JI, Kravitz HM, Brom-
berger JT, Matthews KA. Depressive
symptoms, insulin resistance, and risk of
diabetes in women at midlife. Diabetes
Care 2004;27:2856–2862
7. EngumA.Theroleofdepressionandanx-
iety in onset of diabetes in a large popula-
tion-based study. J Psychosom Res 2007;
62:31–38
8. Carnethon MR, Biggs ML, Barzilay JI,
Smith NL, Vaccarino V, Bertoni AG, Ar-
nold A, Siscovick D. Longitudinal associ-
ation between depressive symptoms and
incident type 2 diabetes mellitus in older
adults: the Cardiovascular Health Study.
Arch Intern Med 2007;167:802–807
9. MezukB,EatonWW,GoldenSH,DingY.
The inﬂuence of educational attainment
on depression and risk of type 2 diabetes.
Am J Public Health 2008;98:1480–1485
10. Golden SH, Lazo M, Carnethon M, Ber-
toni AG, Schreiner PJ, Diez Roux AV, Lee
HB, Lyketsos C. Examining a bidirec-
tional association between depressive
symptomsanddiabetes.JAMA2008;299:
2751–2759
11. Knol MJ, Twisk JWR, Beekman ATF,
HeineRJ,SnoekFJ,PouwerF.Depression
as a risk factor for the onset of type 2 di-
abetes mellitus: a meta-analysis. Diabeto-
logia 2006;49:837–845
12. Mezuk B, Eaton WW, Albrecht S, Golden
SH. Depression and type 2 diabetes over
the lifespan a meta-analysis. Diabetes
Care 2008;31:2383–2390
13. Saydah SH, Brancati FL, Golden SH,
Fradkin J, Harris MI. Depressive symp-
toms and the risk of type 2 diabetes mel-
litus in a US sample. Diabete Metab Res
Rev 2003;19:202–208
14. Rubin RR, Ma Y, Marrero DG, Peyrot M,
Barrett-Connor EL, Kahn SE, Haffner SM,
PriceDW,KnowlerWC,DiabetesPreven-
tion Program Research Group. Elevated
depression symptoms, antidepressant
medicine use, and risk of developing dia-
betes during the Diabetes Prevention Pro-
gram. Diabetes Care 2008;31:420–426
15. Stefﬁck DE, the HRS Health Working
Group. Documentation of affective func-
tioning measures in the Health and
Retirement Study. HRS/AHEAD Documen-
tationReportDR-005[onlinereport],2000.
Available from http://hrsonline.isr.umich.
edu/sitedocs/userg/dr-005.pdf.Accessed5
December 2009
16. Radloff LS. The CES-D scale: a self-report
depression scale for research in the gen-
eralpopulation.ApplPsycholMeas1977;
1:385–401
17. Demakakos P, Nazroo J, Breeze E, Mar-
mot M. Socioeconomic status and health:
the role of subjective social status. Soc Sci
Med 2008;67:330–340
18. Strine TW, Mokdad AH, Dube SR, Balluz
LS, Gonzalez O, Berry JT, Manderscheid
R, Kroenke K. The association of depres-
sion and anxiety with obesity and un-
healthy behaviors among community-
dwelling US adults. Gen Hosp Psychiatry
2008;30:127–137
19. Bassuk SS, Manson JE. Epidemiological
evidencefortheroleofphysicalactivityin
reducing risk of type 2 diabetes and car-
diovascular disease. J Appl Physiol 2005;
99:1193–1204
20. Willi C, Bodenmann P, Ghali WA, Faris
PD,CornuzJ.Activesmokingandtherisk
oftype2diabetes:asystematicreviewand
meta-analysis. JAMA 2007;298:2654–
2664
21. Musselman DL, Betan E, Larsen H, Phil-
lips LS. Relationship of depression to di-
abetes types 1 and 2: epidemiology,
biology, and treatment. Biol Psychiatry
2003;54:317–329
22. Whincup PH, Kaye SJ, Owen CG, Huxley
R, Cook DG, Anazawa S, Barrett-Connor
E, Bhargava SK, Birgisdottir BE, Carlsson
S, de Rooij SR, Dyck RF, Eriksson JG,
Falkner B, Fall C, Forse ´n T, Grill V, Gud-
nasonV,HulmanS,Hyppo ¨nenE,Jeffreys
M, Lawlor DA, Leon DA, Minami J,
Mishra G, Osmond C, Power C, Rich-Ed-
wardsJW,RoseboomTJ,SachdevHS,Sy-
ddall H, Thorsdottir I, Vanhala M,
Wadsworth M, Yarbrough DE. Birth
weight and risk of type 2 diabetes: a sys-
tematic review. JAMA 2008;300:2886–
2897
23. Colman I, Ploubidis GB, Wadsworth ME,
Jones PB, Croudace TJ. A longitudinal ty-
pology of symptoms of depression and
anxiety over the life course. Biol Psychia-
try 2007;62:1265–1271
24. Paile-Hyva ¨rinen M, Ra ¨ikko ¨nen K, Forse ´n
T, Kajantie E, Yliha ¨rsila ¨ H, Salonen MK,
Osmond C, Eriksson JG. Depression and
itsassociationwithdiabetes,cardiovascu-
lar disease, and birth weight. Ann Med
2007;39:634–640
25. PierceMB,ZaninottoP,SteelN,MindellJ.
Undiagnosed diabetes-data from the En-
glish longitudinal study of ageing. Diabet
Med 2009;26:679–685
Demakakos, Pierce, and Hardy
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 4, APRIL 2010 797